CONFERENCE COMMITTEE REP. NO.20-02

Honolulu, Hawaii

, 2002

RE: H.B. No. 223

H.D. 1

S.D. 2

C.D. 1

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-First State Legislature

Regular Session of 2002

State of Hawaii

Honorable Robert Bunda

President of the Senate

Twenty-First State Legislature

Regular Session of 2002

State of Hawaii

Sir:

Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 223, H.D. 1, S.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO OPTOMETRY,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

The purpose of this bill, is to require the Joint Formulary Advisory Committee to use the most current Physician's Desk Reference in developing drug formularies for optometry.

Your Committee on Conference has amended this bill by:

(1) Inserting a findings and purpose section;

(2) Repealing the Joint Formulary Advisory Committee and transferring responsibility for formulary selection to the Board of Examiners in Optometry;

(3) Allowing therapeutically certified optometrists to prescribe and use topical pharmaceuticals approved by the Board of Examiners in Optometry; and

(4) Prohibiting optometrists from using anti-fungal, injectable, or oral agents.

As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 223, H.D. 1, S.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 223, H.D. 1, S.D. 2, C.D. 1.

Respectfully submitted on behalf of the managers:

ON THE PART OF THE SENATE

ON THE PART OF THE HOUSE

____________________________

DAVID M. MATSUURA, Chair

____________________________

DENNIS A. ARAKAKI, Co-Chair

____________________________

RON MENOR, Co-Chair

____________________________

KENNETH T. HIRAKI, Co-Chair